Currently, there are 3.03M common shares owned by the public and among those 2.28M shares have been available to trade.
The company’s stock has a 5-day price change of 167.58% and 68.95% over the past three months. TRAW shares are trading 34.87% year to date (YTD), with the 12-month market performance up to 43.27% higher. It has a 12-month low price of $4.06 and touched a high of $19.94 over the same period. TRAW has an average intraday trading volume of 11.86K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 137.63%, 146.16%, and 28.17% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Traws Pharma Inc (NASDAQ: TRAW) shares accounts for 1.35% of the company’s 3.03M shares outstanding.
It has a market capitalization of $35.79M and a beta (3y monthly) value of 1.12. The earnings-per-share (ttm) stands at -$141.35. Price movements for the stock have been influenced by the stock’s volatility, which stands at 21.54% over the week and 10.53% over the month.
Earnings per share for the fiscal year are expected to decrease by -586.00%, and 76.99% over the next financial year.
Looking at the support for the TRAW, a number of firms have released research notes about the stock. Ladenburg Thalmann stated their Buy rating for the stock in a research note on March 01, 2022, with the firm’s price target at $7. Guggenheim coverage for the Traws Pharma Inc (TRAW) stock in a research note released on May 18, 2021 offered a Buy rating with a price target of $4. H.C. Wainwright on their part issued Buy rating on October 09, 2017.
